Evaluation of Benztropine for Cocaine Craving - 2

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Benztropine

Study type: Interventional

Funder types: Other U.S. Federal agency; NIH

Identifiers

NCT00000333

Y01-3-0009-2

NIDA-3-0009-2

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.

Sex: All

Ages: 22 to 48 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.